ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
31.92
+0.43 (1.35%)
Nov 5, 2024, 11:10 AM EST - Market open

ArriVent BioPharma Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for ArriVent BioPharma stock have an average target of 36.8, with a low estimate of 35 and a high estimate of 39. The average target predicts an increase of 15.31% from the current stock price of 31.92.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $35 $36.8 $36 $39
Change +9.67% +15.31% +12.80% +22.20%
* Price targets were last updated on Sep 11, 2024.

Analyst Ratings

The average analyst rating for AVBP stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating May '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy 444444
Buy 000111
Hold 000000
Sell 000000
Strong Sell 000000
Total 444555

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Citigroup
Citigroup
Strong Buy
Maintains
$30$36
Strong Buy Maintains $30$36 +12.80% Sep 11, 2024
Oppenheimer
Oppenheimer
Buy
Reiterates
$35$39
Buy Reiterates $35$39 +22.20% Sep 10, 2024
Goldman Sachs
Goldman Sachs
Strong Buy
Maintains
$28$38
Strong Buy Maintains $28$38 +19.07% Sep 10, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$30$36
Strong Buy Maintains $30$36 +12.80% Sep 10, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$25$30
Strong Buy Maintains $25$30 -6.00% Aug 16, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.26
from -32.38
EPS Next Year
-2.84
from -3.26
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028
Revenue
-----3.30M102.61M232.10M
Revenue Growth
------3,011.28%126.20%
EPS
-96.75-28.90-32.38-3.26-2.84-3.28--
EPS Growth
--------
Forward PE
--------
No. Analysts ---88744
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High n/a n/a 10.2M
Avg n/a n/a 3.3M
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20242025202620272028
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202420252026
High -2.86 -0.45 -2.14
Avg -3.26 -2.84 -3.28
Low -4.17 -4.09 -4.27

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.